KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

CareDx (CDNA) Shares Outstanding (2016 - 2026)

CareDx's Shares Outstanding history spans 14 years, with the latest figure at $51.3 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding fell 7.55% to $51.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $51.3 million, a 7.55% decrease, with the full-year FY2025 number at $50.9 million, down 7.04% from a year prior.
  • Shares Outstanding hit $51.3 million in Q1 2026 for CareDx, up from $50.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CDNA hit a ceiling of $55.5 million in Q1 2025 and a floor of $50.9 million in Q4 2025.
  • Historically, Shares Outstanding has averaged $53.0 million across 5 years, with a median of $53.2 million in 2025.
  • Biggest five-year swings in Shares Outstanding: grew 7.11% in 2025 and later decreased 7.55% in 2026.
  • Tracing CDNA's Shares Outstanding over 5 years: stood at $53.5 million in 2022, then dropped by 3.79% to $51.5 million in 2023, then grew by 6.34% to $54.8 million in 2024, then dropped by 7.04% to $50.9 million in 2025, then increased by 0.7% to $51.3 million in 2026.
  • Business Quant data shows Shares Outstanding for CDNA at $51.3 million in Q1 2026, $50.9 million in Q4 2025, and $51.4 million in Q3 2025.